Louisiana Appeals Court Reinstates State’s Actos Suit Against Takeda
(April 18, 2016, 1:02 PM EDT) -- BATON ROUGE, La. — A Louisiana appeals panel on April 15 reversed dismissal of several claims brought by the State of Louisiana against Takeda Pharmaceuticals America Inc. for failing to disclose the bladder cancer risk of the company’s Actos diabetes drug (The State Of Louisiana, Ex. Rel. James D. "Buddy" Caldwell v. Takeda Pharmaceuticals America, Inc., et al., No. 2015 CA 1413, La. App., 1st Cir.; 2016 La. App. Unpub. LEXIS 137).
(Opinion available. Document #28-160421-012Z.)
In 2015, Louisiana sued Takeda in the East Baton Rouge...